Identifying Immunological Biomarkers for Major Depressive Disorder: Insights From Machine Learning, Single‐Nucleus Bioinformatics, and Experimental Validation
Key Points
The research aims to explore the connections between major depressive disorder (MDD) and immune system changes, identifying potential biomarkers.
Utilized machine learning techniques for data analysis.
Employed single-nucleus bioinformatics to study cellular activity.
Conducted experimental validation of identified biomarkers.
DACH1, FZD7, and GULP1 were identified as key biomarkers associated with MDD.
Found a strong correlation between immune infiltration and MDD symptoms.
Demonstrated potential therapeutic targets related to these biomarkers.
Abstract
Our findings contribute to the understanding of the relationship between MDD and immune infiltration. DACH1, FZD7, and GULP1 may be key biomarkers and potential therapeutic targets for MDD.
Identifying Immunological Biomarkers for Major Depressive Disorder: Insights From Machine Learning, Single‐Nucleus Bioinformatics, and Experimental Validation | Synapse